Results 171 to 180 of about 20,482 (221)

Case Report: IgG4-RD-related ophthalmopathy combined with monoclonal gammopathy of undetermined significance. [PDF]

Front Immunol
Liang S, Xu W, Zhong P, Tao C, Zhang L, Jia C.   +5 more
europepmc   +1 more source

C3 glomerulonephritis associated with monoclonal gammopathy of renal significance: a diagnostic and therapeutic challenge. [PDF]

J Bras Nefrol
Beirão B, Freitas M, Silva N, Ferraz P, Prata C, Morgado T.   +5 more
europepmc   +1 more source

Data from Asymptomatic Incidence of Monoclonal Gammopathy of Undetermined Significance and Preclinical Duration to Myeloma Diagnosis: A Modeling Study

Mengmeng Ji, Yi-Hsuan Shih, John H. Huber, Mei Wang, Eric J. Feuer, Ruth Etzioni, Shi‐Yi Wang, Su‐Hsin Chang   +7 more
openalex   +1 more source

Diagnostic Complexity in Monoclonal Gammopathy of Thrombotic Significance. [PDF]

N Engl J Med
Kanack AJ, Leung N, Padmanabhan A.
europepmc   +1 more source

Cryfibrinogen-Associated Glomerulonephritis and Monoclonal Gammopathy of Renal Significance-Case Report and Literature Review. [PDF]

J Clin Med
Terzolo E, Solfietti L, Ferro M, Barreca A, Milan M, Fenoglio R, Sciascia S, Roccatello D.   +7 more
europepmc   +1 more source

Synovitis, acne, pustular lesions, hyperostosis, and osteitis syndrome associated with monoclonal gammopathy of undetermined significance: a case report. [PDF]

BMC Musculoskelet Disord
Xu C, Zhang W, Huang X, Han Y.
europepmc   +1 more source

Prevalence and Spectrum of Neuropathies in a Cohort of 585 Patients With Immunoglobulin A Monoclonal Gammopathy. [PDF]

Eur J Neurol
Perrain V, Molinier-Frenkel V, Dupuis J, Créange A, Lefaucheur JP, Gendre T.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Asymptomatic Monoclonal Gammopathies

Clinical Lymphoma Myeloma and Leukemia, 2014
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) represent the earlier phases of plasma cell dyscrasias. Their definition is based on absence of end-organ damage with presence of a malignant clone that grows in the bone marrow.
Claire, Bories, Sundar, Jagannath
openaire   +2 more sources

Subsequent Monoclonal Gammopathies

Oncology, 1984
21 patients with 'subsequent' monoclonal gammopathies which developed after non-tumour or tumour states were studied. The cases were selected from 221 patients producing M protein, partly based on retrospective analysis and partly on data of case history, autopsy, histology, and immunochemistry obtained during continuous observation.
S, Ottó, M, Börzsönyi, S, Eckhardt, A, Pintér, E, Döbrentey, J, Tóth   +5 more
openaire   +2 more sources